Full-fledged restructuring of a business of a large European pharmaceutical company

Lawyers of the practice provided legal support during a project that involved the restructuring of the business of a European pharmaceutical company (group of companies) in Russia. Our specialists drafted a packaged legal memo regarding the potential options for restructuring the business taking into account regulatory, currency, customs and tax risks. In the end, the company decided to follow through with one of the options we suggested.

Lawyers of the practice advised the client on emerging tactical and strategic issues that are connected, among other things, with licensing pharmaceutical activity, modifying logistical chains, remodelling transfer pricing (TP) and so on. In addition, agreements (supply agreements, a bonus agreement and others), the commercial policy and other instruments were drafted within the scope of the project.

The project is of immense importance for the client’s Russian business because with the new approach being implemented the company will be able to carry out necessary transactions in Russia more efficiently, expand the opportunities for operational activity and mitigate business risks.